Literature DB >> 15095963

Radiosurgery for pituitary metastases.

Yoshiyasu Iwai1, Kazuhiro Yamanaka, Yuji Honda, Yasuhiro Matsusaka.   

Abstract

Gamma knife radiosurgery (GKS) was used to treat seven patients with pituitary metastases between November 1994 and February 2003. The diagnoses were based on magnetic resonance imaging and clinical symptoms in six patients and by previous surgery in one patient. The cancer originated in the lung in five patients, and in the breast in two patients. The tumor volume was 0.2 to 9.6 cm3 (mean 4.0 cm3). The marginal dose was 10 to 14 Gy (mean 11.9 Gy) because of the close proximity to the optic apparatus. The maximum radiation dose to the optic apparatus was 8 to 10 Gy (mean 9.5 Gy). The survival period after GKS was 0.3 to 42 months (mean 11.5 months). Five patients died of systemic disease, and one patient died of unknown causes 10 days after GKS. Tumor growth was controlled in five of the six patients (83%) followed up after GKS. Tumor regrowth was seen 18 months after GKS in one patient. The clinical symptoms improved in five of the six patients (83%) followed up. GKS is effective and useful for the primary treatment of pituitary metastases with limited survival and less invasiveness compared to conventional radiation therapy.

Entities:  

Mesh:

Year:  2004        PMID: 15095963     DOI: 10.2176/nmc.44.112

Source DB:  PubMed          Journal:  Neurol Med Chir (Tokyo)        ISSN: 0470-8105            Impact factor:   1.742


  11 in total

1.  Hypofractionated stereotactic radiosurgery for pituitary metastases.

Authors:  Haemin Chon; KyoungJun Yoon; Do Hoon Kwon; Chang Jin Kim; Min-Seon Kim; Young Hyun Cho
Journal:  J Neurooncol       Date:  2017-01-09       Impact factor: 4.130

Review 2.  Metastatic involvement of the pituitary gland: a systematic review with pooled individual patient data analysis.

Authors:  Wenzhuan He; Fangxiang Chen; Brian Dalm; Patricia A Kirby; Jeremy D W Greenlee
Journal:  Pituitary       Date:  2015-02       Impact factor: 4.107

Review 3.  Twelve cases of pituitary metastasis: a case series and review of the literature.

Authors:  Mendel Castle-Kirszbaum; Tony Goldschlager; Benjamin Ho; Yi Yuen Wang; James King
Journal:  Pituitary       Date:  2018-10       Impact factor: 4.107

4.  Efficacy of Trans-septal Trans-sphenoidal Surgery in Correcting Visual Symptoms Caused by Hematogenous Metastases to the Sella and Pituitary Gland.

Authors:  Iman Feiz-Erfan; Ganesh Rao; William L White; Ian E McCutcheon
Journal:  Skull Base       Date:  2008-03

5.  Pituitary metastasis from breast cancer presenting as diabetes insipidus.

Authors:  Joseph F Gormally; Michael A Izard; Bruce G Robinson; Frances M Boyle
Journal:  BMJ Case Rep       Date:  2014-04-12

6.  Extended Survival After Surgical Resection for Pituitary Metastases: Clinical Features, Management, and Outcomes of Metastatic Disease to the Sella.

Authors:  Krupa R Patel; Junting Zheng; Viviane Tabar; Marc A Cohen; Monica Girotra
Journal:  Oncologist       Date:  2019-11-29

7.  Sellar and parasellar metastatic tumors.

Authors:  Tamer Altay; Khaled M Krisht; William T Couldwell
Journal:  Int J Surg Oncol       Date:  2011-10-13

Review 8.  Endometrial adenocarcinoma metastatic to the pituitary gland: a case report and literature review.

Authors:  Hongquan Du; Aihua Jia; Yuan Ren; Mingyong Gu; Haomin Li; Minghui Sun; Tian Tang; Haijuan Liu; Jie Bai
Journal:  J Int Med Res       Date:  2020-06       Impact factor: 1.671

9.  A rare case of pituitary metastasis from breast cancer detected on fluorodeoxyglucose positron emission tomography/computed tomography that presented as insipid diabetes.

Authors:  Omar Ait Sahel; Yassir Benameur; Salah Oueriagli Nabih; Abdelhamid Biyi; Abderrahim Doudouh
Journal:  World J Nucl Med       Date:  2020-10-23

10.  Pituitary metastases: presentation and outcomes from a pituitary center over the last decade.

Authors:  K Lithgow; I Siqueira; L Senthil; H S Chew; S V Chavda; J Ayuk; A Toogood; N Gittoes; T Matthews; R Batra; S Meade; P Sanghera; N Khan; S Ahmed; A Paluzzi; G Tsermoulas; N Karavitaki
Journal:  Pituitary       Date:  2020-06       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.